The PI3K/Akt/mTOR pathway is a central driver of metabolic reprogramming in NSCLC, integrating extracellular signals to promote glucose uptake, glycolytic enzyme expression, and anabolic activity [56]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.